Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01051037 · ClinicalTrials.gov registry record · NA
Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways
A NA study, sponsored by Jonsson Comprehensive Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT01051037 is a NA study that has completed, run by Jonsson Comprehensive Cancer Center. The registered enrollment target is 17 participants.
The verdict
NCT01051037, a NA study, has completed, sponsored by Jonsson Comprehensive Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
Interventions
- RADIATION Stereotactic Body Radiation
- RADIATION Radiofrequency Ablation
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2010-02-08 |
| Est. Completion | 2017-12-20 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01051037
The ClinicalTrials.gov registry entry for NCT01051037 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Jonsson Comprehensive Cancer Center, which has 321 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation is the first listed.
NCT01051037 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01051037 about?
NCT01051037 is a clinical study titled "Stereotactic Body Radiotherapy and Radiofrequency Ablation for Lung Tumors Near Central Airways". The purpose of this study is to demonstrate that combined stereotactic body radiotherapy and radiofrequency ablation is safe for patients with lung tumors near central airways.
What is the current status of trial NCT01051037?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2010-02-08. Estimated completion is 2017-12-20.
What interventions are being tested in trial NCT01051037?
The interventions under investigation include: Stereotactic Body Radiation (RADIATION), Radiofrequency Ablation (RADIATION).
Who is sponsoring clinical trial NCT01051037?
This trial is sponsored by Jonsson Comprehensive Cancer Center, which has 321 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.